Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02303665
Other study ID # 2012SZ0086
Secondary ID
Status Completed
Phase Phase 2
First received November 21, 2014
Last updated March 8, 2017
Start date November 2014
Est. completion date March 2016

Study information

Verified date March 2017
Source Chengdu University of Traditional Chinese Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with ART Failure; to choose the best TCM interventional therapeutic plan.

Methods: The cases with ART Failure from West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) meeting the inclusion criteria were randomly divided into three groups: the dual therapy group, the triple therapy group and the control group, compare the natural pregnancy number, the condition during the period of secondary IVF-ET and the improvement of the kidney deficiency, liver depression and blood stasis syndrome among those three groups.


Description:

Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with ART Failure; to choose the best TCM interventional therapeutic plan.

Methods: The cases with ART Failure from West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) meeting the inclusion criteria were randomly divided into three groups: the dual therapy group, the triple therapy group and the control group, compare the natural pregnancy number, the condition during the period of secondary IVF-ET and the improvement of the kidney deficiency, liver depression and blood stasis syndrome among those three groups.

The results will show the effect of TCM multi-channel interventional therapy for patients with ART failure


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date March 2016
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Female
Age group 24 Years to 43 Years
Eligibility Inclusion Criteria:

1. People aged 20 to 45

2. People with IVF - ET indications

3. People from Reproductive Center of West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) with long plan for IVE - ET Failure and then accept the secondary IVF-ET

4. People who conform to the standard of syndrome differentiation in TCM: kidney deficiency and liver depression and blood stasis

5. People with normal basic sex hormone levels

6. People who have recognized and voluntarily signed the informed consent. NOTICE: People who conform to the above 6 items can be included.

Exclusion Criteria:

1. People don't meet the inclusion criteria

2. The husband with less sperm and weak sperm seriously

3. People who have drug allergy or allergic constitution

4. People with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, etc. And mentally disordered patients

5. People who are complicated by acute infectious diseases and organic diseases

6. People have confirmed diagnosis malformed reproductive organs, reproductive system inflammation and tumors upon examination

7. People suffer from hereditary disease which is not suitable for fertility regulated in "maternal and infant health care law"

8. People who have the serious bad habits such as drug use

9. People who have contacted with birth defects rays, poison, drugs to a certain number and being in effect; NOTICE: People who conform to any of the terms above 9 will be ruled out.

Study Design


Related Conditions & MeSH terms

  • Failure After Assisted Reproductive Technology

Intervention

Other:
The dual therapy
TCM prescription?of cultivated emotion and assisted reproduction +auricular acupoint therapy
The triple therapy
TCM prescription?of cultivated emotion and assisted reproduction + auricular acupoint therapy+ retention enema of TCM

Locations

Country Name City State
China West China second University Hospital of Sichuan University Chendu Sichuan

Sponsors (1)

Lead Sponsor Collaborator
Chengdu University of Traditional Chinese Medicine

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of patients with sucessful conception 10 weeks after embryo transplantation
Secondary Time to have successful conception up to 26 weeks
Secondary Adverse events 0, 10, 26 weeks after randomization
See also
  Status Clinical Trial Phase
Completed NCT03078205 - Observation on the Curative Effect of Assisted Reproduction by TCM Multi-channel Interventional Therapy N/A